Improving delivery of hydrophobic drugs from hydrogels through cyclodextrins

Journal of Biomedical Materials Research - Part A

Volumn 74, Issue 3, 2005, Pages 454-460

  Kanjickal, Deenu ^a   Lopina, Stephanie ^a   Evancho Chapman, M Michelle ^b   Schmidt, Steven ^b   Donovan, Duane ^b  

^a The University of Akron   (United States)

^b SUMMA HEALTH SYSTEM   (United States)

Author keywords

Complexation; Cyclodextrin; Cyclosporine; Drug delivery; Hydrogel; Poly(ethylene glycol) (PEG)

Indexed keywords

COMPLEXATION; CROSSLINKING; HYDROGELS; HYDROPHOBICITY; POLYETHYLENE GLYCOLS;

COMPLEXANTS; CYCLODEXTRIN; CYCLOSPORINE; DRUG DELIVERY;

DRUG PRODUCTS;

CYCLODEXTRIN; CYCLOSPORIN A; MACROGOL;

ARTICLE; COMPLEX FORMATION; CROSS LINKING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; HYDROGEL; HYDROPHOBICITY; INSTRUMENT STERILIZATION; NONHUMAN; SYNTHESIS; VASCULAR TISSUE;

CYCLODEXTRINS; CYCLOSPORINE; DRUG DELIVERY SYSTEMS; HYDROGELS; HYDROPHOBICITY; POLYETHYLENE GLYCOLS;

EID: 23844488481     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.30374     Document Type: Article

References (47)

1. Soppimath KS, Kulkarni AR, Aminabhavi TM. Controlled release of antihypertensive drug from the interpenetrating network poly(vinyl alcohol)-guar gum hydrogel microspheres. J Biomater Sci Polym Ed 2000;11:27-43.
2. Garcia O, Blanco MD, Martin JA, Teijon JM. 5-Fluorouracil trapping in poly(2-hydroxyethyl methacrylate-co-acrylamide) hydrogels: in vitro drug delivery studies. Eur Polym J 2000;36: 111-122.
3. Chacon D, Hsieh YL, Kurth MJ, Krochta JM. Swelling and protein absorption/desorption of thermo-sensitive lactitol-based polyether polyol hydrogels. Polymer 2000;41:8257-8262.
4. Cheng J, Jo S, Park K. Polysaccharide hydrogels for protein drug delivery. Carbohydr Polym 1995;28:69-76.
5. Tanaka T. Gels. In: Mark HF, Bikales NM, Overberger CG, Merges G, editors. Encyclopedia of polymer science and engineering. 2nd ed. Vol. 7. New York: Wiley; 1987. p 514-531.
6. Lim YH, Kim D, Lee DS. Drug releasing characteristics of thermo- and pH-sensitive interpenetrating polymer networks based on poly(N- isopropylacrylamide). J Appl Polym Sci 1997; 64:2647-2655.
7. Kaneko Y, Yoshida R, Sakai K, Sakurai Y, Okano T. Temperature-responsive shrinking kinetics of poly(N-isopropylacrylamide) copolymer gels with hydrophilic and hydrophobic comonomers. J Membr Sci 1995;101:13-22.
8. Kondo A, Kishimura M, Katoh S, Sada E. Improvement of proteolytic resistance of immunoadsorbents by chemical modification with polyethylene glycol. Biotech Bioeng 1989;34:532-540.
9. Herold DA, Keil KA, Bruns DE. Oxidation of polyethylene glycols by alcohol dehydrogenase. Biochem Pharmacol 1989; 38:73-76.
10. Smyth HF Jr, Carpenter CP, Weil CS. The toxicology of the polyethylene glycols. J Am Pharm Assoc 1950;39:349-354.
11. Johnson AJ, Darpatkin MH, Newman J, Margaret H. Clinical investigation of intermediate and high-purity antihemophilic factor (factor VIII) concentrates. Br J Hematol 1971;21:21-41.
12. Shaffer CB, Critchfield FH. The absorption and excretion of the solid polyethylene glycols (carbowax compounds). J Am Pharm Assoc 1947;36:152-257.
13. Harris JM. Poly(ethylene glycol) chemistry: Biotechnical and biomedical applications. New York: Plenum Press; 1992. p 1-14.
14. Peppas NA, Keys KB, Torres-Lugo M, Lowman AM. Poly(ethylene glycol)-containing hydrogels in drug delivery. J Controlled Release 1999;62:81-87.
15. Stringer JL, Peppas NA. Diffusion of small molecular weight drugs in radiation-crosslinked poly(ethylene oxide) hydrogels. J Controlled Release 1996;42:195-202.
16. Merrill EW, Dennison KA, Sung C. Partitioning and diffusion of solutes in hydrogels of poly(ethylene oxide). Biomaterials 1993;14(15):1117-1126.
17. Iza M, Stoianovici G, Viora L, Grossiord JL, Couarraze G. Hydrogels of poly(ethylene glycol): Mechanical characterization and release of a model drug. J Controlled Release 1998;52: 41-51.
18. Graham NB, Mcneill ME. Hydrogels for controlled drug delivery. Biomaterials 1984;5:27-36.
19. Kanjickal D, Stephanie L, Evancho-Chapman MM, Schmidt S, Donovan D. Polymeric sustained local drug delivery system for the prevention of vascular intimal hyperplasia. J Biomed Mater Res 2004;68:489-495.
20. Katime I, Rosa N, Diaz de Apodaca E, Rodriguez E. Release of theophylline and aminophylline from acrylic acid/n-alkyl methacrylate hydrogels. J Polym Sci Part A Polym Chem 2004; 42:2756-2765.
21. Lee WF, Chiu RJ. Investigation of charge effects on drug release behavior for ionic thermosensitive hydrogels. Mater Sci Eng C 2002;20:161-166.
22. Zhuo RX, Li W. Preparation and characterization of macroporous poly(N-isopropylacrylamide) hydrogels for the controlled release of proteins. J Polym Sci Part A Polym Chem 2003;41:152-159.
23. Shantha KL, Harding DR. Synthesis, characterization, and evaluation of poly[lactose acrylate-N-vinyl-2-pyrrolidinone] hydrogels for drug delivery. Eur Polym J 2003;39:63-68.
24. Rathna GV. Hydrogels of modified ethylenediaminetetraacetic dianhydride gelatin conjugated with poly(ethylene glycol) dialdehyde as a drug-release matrix. J Appl Polym Sci 2004;91: 1059-1067.
25. Podual K, Doyle FJ III, Peppas NA. Preparation and dynamic response of cationic copolymer hydrogels containing glucose oxidase. Polymer 2000;41:3975-3983.
26. Franssen O, Vos OP, Hennick WE. Delayed release of a model protein from enzymatically-degrading dextran hydrogels. J Controlled Release 1997;44:237-245.
27. Kamath KR, Park K. Study on the release of invertase from enzymatically degradable dextran hydrogels. Polym Gels Networks 1995;3:243-254.
28. Shalaby A, Abdallah AA, Park H, Park K. Loading of bovine serum albumin into hydrogels by an electrophoretic process and its potential applications to protein drugs. Pharm Res 1993;10:457-460.
29. Gehrke SH, Vaid N, Uhden L. Enhanced protein loading in hydrogels. Proc Int Symp Controlled Release Bioact Mater 1993;20:113-114.
30. Park H, Shalaby W, Park K. Biodegradable hydrogels for drug delivery. Lancaster, PA: Technomic Publishing; 1993.
31. Siegel RA, Falamarzian M, Firestone AB, Moxley BC. pH-controlled dependent release from hydrophobic-polyelectrolyte copolymer hydrogels. J Controlled Release 1988;8:179-182.
32. Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci 1996;85:1017-1025.
33. Bergeron RJ. Cycloamylose-substrate binding. In: Attwood JL, Bavies JV, editors. Inclusion compounds. London: Academic Press; 1984. p 391-443.
34. Stella VJ, Rajewski RA. Cyclodextrins: Their future in drug formulation and delivery. Pharm Res 1997;14:556-567.
35. Ptachcinski RJ, Venkataramanan R, Burckart GJ. Clinical pharmacokinetics of cyclosporin. Clin Pharmacokinet 1986;11:107-132.
36. Calne RY, White DJ, Thiru S, Evans DB, McMaster P, Dunn DC, Craddock GN, Pentlow BD, Rolles K. Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet 1978;2:1323-1327.
37. Calne RY. Cyclosporin. Nephron 1980;26:57-63.
38. Mehta M, Venkataramanan R, Buckart GJ. Effects of bile on cyclosporin absorption in liver transplant patients. Br J Clin Pharmacol 1984;25:579-584.
39. Yee GC, McGuire TR. Pharmacokinetic drug interactions with cyclosporin (Part I). Clin Pharmacokinet 1990;19:319-332.
40. Campana C, Regazzi MB, Buggia I, Molinaro M. Clinically significant drug interactions with cyclosporin. An update. Clin Pharmacokinet 1996;30:141-179.
41. Yoshikawa M, Shiota A, Sanui K, Ogata N. Preparation of polyoxyethylene hydrogel membranes and their ultrafiltration performance. New Polym Mater 1989;1(3):223-234.
42. TDx/TDxFLx® cyclosporin monoclonal whole blood, Abbott Laboratories, Diagnostics Division, Abbott Park, IL 60064. List no. 9797-60, 69-4972/R6, July 2000.
43. Point JJ, Damman P. Structure of a new crystalline complex: poly(ethylene oxide) with p-nitrophenol. Macromolecules 1992;25:1184-1188.
44. Frank DW, Gray JE, Weaver RN. Cyclodextrin nephrosis in the rat. Am J Pathol 1976;83:367-382.
45. Antlsperger G, Schmid G. Toxicological comparison of cyclodextrins. In: Proceedings of the 8th international symposium on cyclodextrins. Dordrecht: Kluwer Academic Publishers; 1996. p 149-155.
46. Miyake K, Irie T, Hirayama F, Uekama K. Improvements of gastrointestinal absorption and lymphatic transfer of cyclosporin A by various cyclodextrins. Drug delivery system. 1998; 13:369-375.
47. Miyake K, Hirayama F, Uekama K. Solubility and mass and nuclear magnetic resonance spectroscopic studies on interaction of cyclosporin A with dimethyl-alpha- and -beta-cyclodextrins in aqueous solution. J Pharm Sci 1999;88:39-45.